Logo
PATIENT DERIVED XENOGRAFT MODEL MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)
  2. / Industry Reports
  3. Table of Content - Patient Derived Xenograft Model Market Analysis
all report title image

PATIENT DERIVED XENOGRAFT MODEL MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Patient Derived Xenograft Model Market, By Model Type (Cell line derived models, Patient derived organoids, Genetically engineered models and Others (Primary cell derived models, cell processed models etc.)), By Implantation Method (Subcutaneous Implantation, Orthopedic Implantation and Others), By Tumor Type (Blood Cancer Models, Solid Tumor Models, Pediatric Tumor Models, Other Rare Tumor Models, Combination PDX Models, Custom PDX Models, Others), By Application (Gastrointestinal Tumor Model, Gynecological Tumor Model, Respiratory Tumor Model and Other Tumor Model), By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutions, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Nov 2023
  • Code : CMI6506
  • Pages :140
  • Formats :
      Excel and PDF
  • Industry : Biotechnology
Ingographics Image
N/A

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Patient Derived Xenograft Model, By Model Type
      • Market Patient Derived Xenograft Model, By Implantation Method
      • Market Patient Derived Xenograft Model, By Tumor Type
      • Market Patient Derived Xenograft Model, By End User
      • Market Patient Derived Xenograft Model, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
        • Increasing Cancer Research
      • Restraints
        • Limitations of PDX Models
      • Opportunities
        • Applications in Immunotherapy Testing
    • Impact Analysis 
    • Key Highlights
    • Regulatory Scenario
    • Product launch/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Patient Derived Xenograft Model Market – Impact of Coronavirus (COVID-19) Pandemic
    • COVID-19 Epidemiology
    • Supply Side and Demand Side Analysis
    • Economic Impact
  5. Patient Derived Xenograft Model Market , By Model Type, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019 – 2030
      • Segment Trends
    • Tumor explant models
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
    • Cell line derived models
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
    • Patient derived organoids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
    • Genetically engineered models
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
    • Others (Primary cell derived models, cell processed models etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  6. Patient Derived Xenograft Model Market , By Model Type, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019 – 2030
      • Segment Trends
    • Subcutaneous Implantation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
    • Orthopedic Implantation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  7. Patient Derived Xenograft Model Market , By Tumor Type, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023and 2030 (%)
      • Y-o-Y Growth Analysis, 2018– 2030
    • Gastrointestinal Tumor Model
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
    • Gynecological Tumor Model
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
    • Respiratory Tumor Model
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
    • Other Tumor Model
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  8. Patient Derived Xenograft Model Market , By End User, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023and 2030 (%)
      • Y-o-Y Growth Analysis, 2018– 2030
      • Segment Trends
    • Pharmaceutical & Biotechnology Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
    • Contract Research Organizations
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
    • Academic & Research Institutions
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  9. Patient Derived Xenograft Model Market , By Region, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Country, 2023and 2030 (%)
      • Y-o-Y Growth Analysis, For Country 2019–2030
      • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  10. Competitive Landscape
    • THE JACKSON LABORATORY
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Champions Oncology, Inc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Charles River Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Crown Bioscience
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Hera Biolabs
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Horizon Discovery Group
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Oncodesign
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Pharmatest Services
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Shanghai LIDE Biotech
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Aragen Life Sciences Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Creative Animodel
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Urosphere
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Applied StemCell
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • WuXi AppTec
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Analyst Views
  11. Section
    • Research Methodology
    • About us

*Browse 44 market data tables and 40 figures on “Patient Derived Xenograft Model Market” - Global forecast to 2030

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.